Nasal polyposis– Market outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2020 To 2030
Nasal polyposis is a chronic inflammatory disease of the mucous membranes in the nose and paranasal sinuses presenting as pedunculated smooth, gelatinous, semitranslucent, round, or pear-shaped masses of inflamed mucosa prolapsing into the nose. Etiology- The exact cause of nasal polyps is unknown. Epidemiology- In the general population, the overall prevalence rate of nasal polyposis ranges from 1-4%. The competitive landscape of Nasal polyposis includes country-specific approved as well as pipeline therapies. Any asset/product-specific designation or review and Accelerated Approval are being tracked and supplemented with analyst commentary. KOLs insights of Nasal polyposis across 8 MM market from the center of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs. Nasal polyposis Market Forecast: Patient Based Forecast...